BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Glassock RJ, Warnock DG, Delanaye P. The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol. 2017;13:104-114. [PMID: 27941934 DOI: 10.1038/nrneph.2016.163] [Cited by in Crossref: 128] [Cited by in F6Publishing: 168] [Article Influence: 21.3] [Reference Citation Analysis]
Number Citing Articles
1 Jin Y, He Y, Di X, Fu L, Qi X, Liu R, Zheng L, Wang Y, Zhong H, Wang Z. Simultaneous determination and pharmacokinetics study of valsartan, sacubitril and its major metabolite in human plasma, urine and peritoneal dialysis fluid in patients with end-stage renal disease by UPLC–MS/MS. Journal of Chromatography B 2022;1208:123402. [DOI: 10.1016/j.jchromb.2022.123402] [Reference Citation Analysis]
2 Huang L, Jia K, Xiong H, Tian G, Xu J, Yuan W, Lu C, Xiao X, Lu H. Oxyfluorfen exposure can cause acute kidney injury by promoting ROS-induced oxidative stress and inflammation in zebrafish. Journal of Hazardous Materials 2022;440:129823. [DOI: 10.1016/j.jhazmat.2022.129823] [Reference Citation Analysis]
3 Popp B, Ekici AB, Knaup KX, Schneider K, Uebe S, Park J, Bafna V, Meiselbach H, Eckardt K, Schiffer M, Reis A, Kraus C, Wiesener M. Prevalence of hereditary tubulointerstitial kidney diseases in the German Chronic Kidney Disease study. Eur J Hum Genet. [DOI: 10.1038/s41431-022-01177-9] [Reference Citation Analysis]
4 Paul Owens E, Grania Healy H, Andrew Vesey D, Elizabeth Hoy W, Carolyn Gobe G. Targeted biomarkers of progression in chronic kidney disease. Clin Chim Acta 2022:S0009-8981(22)01283-9. [PMID: 36041551 DOI: 10.1016/j.cca.2022.08.025] [Reference Citation Analysis]
5 Sun H, Shi K, Zuo B, Zhang X, Liu Y, Sun D, Wang F. Kidney-Targeted Drug Delivery System Based on Metformin-Grafted Chitosan for Renal Fibrosis Therapy. Mol Pharm 2022. [PMID: 35938707 DOI: 10.1021/acs.molpharmaceut.1c00827] [Reference Citation Analysis]
6 Gouvêa ECDP, Szwarcwald CL, Damacena GN, Moura L. Self-report of medical diagnosis of chronic kidney disease: prevalence and characteristics in the Brazilian adult population, National Health Survey 2013 and 2019. Epidemiol Serv Saude 2022;31:e2021385. [PMID: 35920461 DOI: 10.1590/SS2237-9622202200017.especial] [Reference Citation Analysis]
7 Yu XA, Zhang L, Zhang R, Bai X, Zhang Y, Hu Y, Wu Y, Li Z, Wang B, Tian J. Accurate identification of kidney injury progression via a fluorescent biosensor array. Mikrochim Acta 2022;189:304. [PMID: 35915355 DOI: 10.1007/s00604-022-05380-9] [Reference Citation Analysis]
8 Wu R, Luo P, Luo M, Li X, Zhong X, He Q, Zhang J, Zhang Y, Xiong Y, Han P. Genetically predicted adiponectin causally reduces the risk of chronic kidney disease, a bilateral and multivariable mendelian randomization study. Front Genet 2022;13:920510. [DOI: 10.3389/fgene.2022.920510] [Reference Citation Analysis]
9 Schaeffner ES, Ebert N, Kuhlmann MK, Martus P, Mielke N, Schneider A, van der Giet M, Huscher D. Age and the Course of GFR in Persons Aged 70 and Above. Clin J Am Soc Nephrol 2022:CJN. [PMID: 35850785 DOI: 10.2215/CJN.16631221] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xu H, Li S, Liu YS. Nanoparticles in the diagnosis and treatment of vascular aging and related diseases. Signal Transduct Target Ther 2022;7:231. [PMID: 35817770 DOI: 10.1038/s41392-022-01082-z] [Reference Citation Analysis]
11 Pesce F, Pasculli D, Pasculli G, De Nicola L, Cozzolino M, Granata A, Gesualdo L. "The Disease Awareness Innovation Network" for chronic kidney disease identification in general practice. J Nephrol 2022. [PMID: 35701727 DOI: 10.1007/s40620-022-01353-6] [Reference Citation Analysis]
12 Liu W, Gao Y, Zhou Y, Yu F, Li X, Zhang N. Mechanism of Cordyceps sinensis and its Extracts in the Treatment of Diabetic Kidney Disease: A Review. Front Pharmacol 2022;13:881835. [DOI: 10.3389/fphar.2022.881835] [Reference Citation Analysis]
13 Yao J, Peng Q, Li Y, Liang A, Xie J, Zhuang X, Chen R, Chen Y, Wang Z, Zhang L, Cao D. Clinical Relevance of Body Fluid Volume Status in Diabetic Patients With Macular Edema. Front Med (Lausanne) 2022;9:857532. [PMID: 35492357 DOI: 10.3389/fmed.2022.857532] [Reference Citation Analysis]
14 Fan LL, Du R, Liu JS, Jin JY, Wang CY, Dong Y, He WX, Yan RQ, Xiang R. Loss of RTN3 phenocopies chronic kidney disease and results in activation of the IGF2-JAK2 pathway in proximal tubular epithelial cells. Exp Mol Med 2022;54:653-61. [PMID: 35596061 DOI: 10.1038/s12276-022-00763-7] [Reference Citation Analysis]
15 Fuhrmann M, Schwaeble Santamaria A, Scott R, Meeusen JW, Fernandes M, Venz J, Rothe V, Stämmler F, Ehrich J, Schiffer E. Analytical Validation of GFRNMR: A Blood-Based Multiple Biomarker Assay for Accurate Estimation of Glomerular Filtration Rate. Diagnostics 2022;12:1120. [DOI: 10.3390/diagnostics12051120] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Han L, Zou Y, Yu C. Targeting CC chemokine ligand (CCL) 20 by miR-143-5p alleviate lead poisoning-induced renal fibrosis by regulating interstitial fibroblasts excessive proliferation and dysfunction. Bioengineered 2022;13:11156-68. [PMID: 35485286 DOI: 10.1080/21655979.2022.2062106] [Reference Citation Analysis]
17 Tang Y, Hou L, Sun T, Li S, Cheng J, Xue D, Wang X, Du Y. Improved equations to estimate GFR in Chinese children with chronic kidney disease. Pediatr Nephrol. [DOI: 10.1007/s00467-022-05552-y] [Reference Citation Analysis]
18 Sun Y, Qiu Z, Wen F, Yin J, Zhou H, Lu H. Revealing Potential Diagnostic Gene Biomarkers Associated with Immune Infiltration in Patients with Renal Fibrosis Based on Machine Learning Analysis. Journal of Immunology Research 2022;2022:1-20. [DOI: 10.1155/2022/3027200] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Hsu YC, Ho C, Shih YH, Ni WC, Li YC, Chang HC, Lin CL. Knockout of KLF10 Ameliorated Diabetic Renal Fibrosis via Downregulation of DKK-1. Molecules 2022;27:2644. [PMID: 35565995 DOI: 10.3390/molecules27092644] [Reference Citation Analysis]
20 Chou P, Wu P, Wu P, Huang T, Huang J, Chen S, Lee S, Kuo M, Chiu Y, Hsu Y, Chang J, Hwang S. Investigation of the Relationship between Cardiovascular Biomarkers and Brachial–Ankle Pulse Wave Velocity in Hemodialysis Patients. JPM 2022;12:636. [DOI: 10.3390/jpm12040636] [Reference Citation Analysis]
21 Rohloff P, Miller AC, Barnoya J, Montano CM. Indexing Estimates of Glomerular Filtration Rate to Body Surface Area in Low-Resource Settings with a High Burden of Malnutrition: Evidence from Guatemala. Kidney International Reports 2022. [DOI: 10.1016/j.ekir.2022.04.007] [Reference Citation Analysis]
22 Xiao H, Shao X, Gao P, Zou H, Zhang X. Metabolic Syndrome Components and Chronic Kidney Disease in a Community Population Aged 40 Years and Older in Southern China: A Cross-Sectional Study. Diabetes Metab Syndr Obes 2022;15:839-48. [PMID: 35321352 DOI: 10.2147/DMSO.S353305] [Reference Citation Analysis]
23 Hornum M, Houlind MB, Iversen E, Porrini E, Luis-Lima S, Oturai P, Iversen M, Bredahl P, Carlsen J, Møller CH, Andersen MJ, Feldt-Rasmussen B, Perch M. Estimating Renal Function Following Lung Transplantation. J Clin Med 2022;11:1496. [PMID: 35329822 DOI: 10.3390/jcm11061496] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Mahadeo A, Yeung CK, Himmelfarb J, Kelly EJ. Kidney microphysiological models for nephrotoxicity assessment. Current Opinion in Toxicology 2022. [DOI: 10.1016/j.cotox.2022.03.002] [Reference Citation Analysis]
25 Calsolaro V, Okoye C, Rogani S, Calabrese AM, Dell'Agnello U, Antognoli R, Guarino D, Monzani F. Different glomerular filtration rate estimating formula for prescribing DOACs in oldest patients: appropriate dosage and bleeding risk. Post hoc analysis of a prospective cohort. Aging Clin Exp Res 2022;34:591-8. [PMID: 34661901 DOI: 10.1007/s40520-021-01986-w] [Reference Citation Analysis]
26 Kabore NF, Cournil A, Poda A, Ciaffi L, Binns-roemer E, David V, Eymard-duvernay S, Zoungrana J, Semde A, Sawadogo AB, Koulla-shiro S, Kouanfack C, Ngom-gueye NF, Meda N, Winkler C, Limou S. APOL1 Renal Risk Variants and Kidney Function in HIV-1–Infected People From Sub-Saharan Africa. Kidney International Reports 2022;7:483-93. [DOI: 10.1016/j.ekir.2021.10.009] [Reference Citation Analysis]
27 Liang M, Zhang D, Zheng D, He W, Jin J. Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis. Bioengineered 2022;13:4517-27. [PMID: 35137672 DOI: 10.1080/21655979.2022.2033465] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Liu X, Zhou H, Li G, Li F, Dong L, Wang S, Jiang Z, Tan J, Qin A, Tang Y, Qin W. Nocturnal heart rate rising is a risk factor for poor renal outcomes in patients with chronic kidney disease and hypertension. J Clin Hypertens (Greenwich) 2022. [PMID: 35130369 DOI: 10.1111/jch.14428] [Reference Citation Analysis]
29 Shi Y, Hu L, Li M, Zhou W, Wang T, Zhu L, Bao H, Cheng X, Li P. Association Between the Surrogate Markers of Insulin Resistance and Chronic Kidney Disease in Chinese Hypertensive Patients. Front Med 2022;9:831648. [DOI: 10.3389/fmed.2022.831648] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Khan MA, Kassianos AJ, Hoy WE, Alam AK, Healy HG, Gobe GC. Promoting Plant-Based Therapies for Chronic Kidney Disease. J Evid Based Integr Med 2022;27:2515690X221079688. [PMID: 35243916 DOI: 10.1177/2515690X221079688] [Reference Citation Analysis]
31 Samaan F, Fernandes DE, Kirsztajn GM, Sesso RDCC, Malik AM. Quality indicators for primary health care in chronic kidney disease in the public service of a city in the State of São Paulo, Brazil. Cad Saúde Pública 2022;38:e00090821. [DOI: 10.1590/0102-311x00090821] [Reference Citation Analysis]
32 Varghese R, Majumdar A. A New Prospect for the Treatment of Nephrotic Syndrome Based on Network Pharmacology Analysis. Current Research in Physiology 2022;5:36-47. [DOI: 10.1016/j.crphys.2021.12.004] [Reference Citation Analysis]
33 Butler CR, Appelbaum PS, Ascani H, Aulisio M, Campbell CE, de Boer IH, Dighe AL, Hall DE, Himmelfarb J, Knight R, Mehl K, Murugan R, Rosas SE, Sedor JR, O'Toole JF, Tuttle KR, Waikar SS, Freeman M; Kidney Precision Medicine Project. A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project. Am J Kidney Dis 2021:S0272-6386(21)01008-8. [PMID: 34871700 DOI: 10.1053/j.ajkd.2021.10.006] [Reference Citation Analysis]
34 Shao M, Ye C, Bayliss G, Zhuang S. New Insights Into the Effects of Individual Chinese Herbal Medicines on Chronic Kidney Disease. Front Pharmacol 2021;12:774414. [PMID: 34803715 DOI: 10.3389/fphar.2021.774414] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
35 Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain. Nefrología (English Edition) 2021;41:670-88. [DOI: 10.1016/j.nefroe.2022.01.008] [Reference Citation Analysis]
36 Rahman HH, Niemann D, Munson-McGee SH. Association of albumin to creatinine ratio with urinary arsenic and metal exposure: evidence from NHANES 2015-2016. Int Urol Nephrol 2021. [PMID: 34643861 DOI: 10.1007/s11255-021-03018-y] [Reference Citation Analysis]
37 Lu Z, Zhu X, Ye Y, Fu H, Mao J. PP2A protects podocytes against Adriamycin-induced injury and epithelial-to-mesenchymal transition via suppressing JIP4/p38-MAPK pathway. Cytotechnology 2021;73:697-713. [PMID: 34629746 DOI: 10.1007/s10616-021-00484-1] [Reference Citation Analysis]
38 Zhou Y, Kim C, Pablo JLB, Zhang F, Jung JY, Xiao L, Bazua-Valenti S, Emani M, Hopkins CR, Weins A, Greka A. TRPC5 Channel Inhibition Protects Podocytes in Puromycin-Aminonucleoside Induced Nephrosis Models. Front Med (Lausanne) 2021;8:721865. [PMID: 34621762 DOI: 10.3389/fmed.2021.721865] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Yang M, Geng CA, Liu X, Guan M. Lipid Disorders in NAFLD and Chronic Kidney Disease. Biomedicines 2021;9:1405. [PMID: 34680522 DOI: 10.3390/biomedicines9101405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
40 Lai CF, Wang JJ, Tu YC, Hsu CY, Wu HY, Fang CC, Chen YM, Wu MS, Tsai TJ. Associations between urinary cysteine-rich protein 61 excretion and kidney function decline in outpatients with chronic kidney disease: a prospective cohort study in Taiwan. BMJ Open 2021;11:e051165. [PMID: 34615677 DOI: 10.1136/bmjopen-2021-051165] [Reference Citation Analysis]
41 Li Y, Chakraborty A, Broughton BRS, Ferens D, Widdop RE, Ricardo SD, Samuel CS. Comparing the renoprotective effects of BM-MSCs versus BM-MSC-exosomes, when combined with an anti-fibrotic drug, in hypertensive mice. Biomed Pharmacother 2021;144:112256. [PMID: 34607108 DOI: 10.1016/j.biopha.2021.112256] [Reference Citation Analysis]
42 Zhao W; Department of Thyroid Surgery, West China Hospital, Sichuan University, Chengdu 610041, China. KDClassifier: A urinary proteomic spectra analysis tool based on machine learning for the classification of kidney diseases. APT 2021;3:63-72. [DOI: 10.31491/apt.2021.09.064] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Meng X, Zou H, Li D, Yu P, Huang L, Zhang J, Li W, Yu X. Association of Circulating ANGPTL8 Levels With Renal Dysfunction: A Case-Control Study. Front Public Health 2021;9:710504. [PMID: 34557469 DOI: 10.3389/fpubh.2021.710504] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
44 Kim H, Lee H, Kwon SH, Jeon JS, Noh H, Han DC, Kim H. Relationship between carbohydrate-to-fat intake ratio and the development of chronic kidney disease: A community-based prospective cohort study. Clin Nutr 2021;40:5346-54. [PMID: 34555715 DOI: 10.1016/j.clnu.2021.09.001] [Reference Citation Analysis]
45 Li Y, Li W, Lu Y, Zhang J. Coffee consumption is associated with a decreased risk of incident chronic kidney disease: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e27149. [PMID: 34664840 DOI: 10.1097/MD.0000000000027149] [Reference Citation Analysis]
46 Mariat C, Mjøen G, Watschinger B, Sever MS, Crespo M, Peruzzi L, Oniscu GC, Abramowicz D, Hilbrands L, Maggiore U. Assessment of Pre-Donation Glomerular Filtration Rate: Going Back To Basics A Position Paper from the DESCARTES Working Group of the ERA-EDTA. Nephrol Dial Transplant 2021:gfab259. [PMID: 34519827 DOI: 10.1093/ndt/gfab259] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Walbaum M, Scholes S, Rojas R, Mindell JS, Pizzo E. Projection of the health and economic impacts of Chronic kidney disease in the Chilean population. PLoS One 2021;16:e0256680. [PMID: 34495980 DOI: 10.1371/journal.pone.0256680] [Reference Citation Analysis]
48 Hossain A, Chowdhury SI, Sarker S, Ahsan MS. Artificial neural network for the prediction model of glomerular filtration rate to estimate the normal or abnormal stages of kidney using gamma camera. Ann Nucl Med 2021;35:1342-52. [PMID: 34491539 DOI: 10.1007/s12149-021-01676-7] [Reference Citation Analysis]
49 Gama RM, Clery A, Griffiths K, Heraghty N, Peters AM, Palmer K, Kibble H, Vincent RP, Sharpe CC, Cairns H, Bramham K. Estimated glomerular filtration rate equations in people of self-reported black ethnicity in the United Kingdom: Inappropriate adjustment for ethnicity may lead to reduced access to care. PLoS One 2021;16:e0255869. [PMID: 34383841 DOI: 10.1371/journal.pone.0255869] [Reference Citation Analysis]
50 Figuer A, Bodega G, Tato P, Valera G, Serroukh N, Ceprian N, de Sequera P, Morales E, Carracedo J, Ramírez R, Alique M. Premature Aging in Chronic Kidney Disease: The Outcome of Persistent Inflammation beyond the Bounds. Int J Environ Res Public Health 2021;18:8044. [PMID: 34360333 DOI: 10.3390/ijerph18158044] [Reference Citation Analysis]
51 Ahn SY, Choi YJ, Kim J, Ko GJ, Kwon YJ, Han K. The beneficial effects of menopausal hormone therapy on renal survival in postmenopausal Korean women from a nationwide health survey. Sci Rep 2021;11:15418. [PMID: 34326358 DOI: 10.1038/s41598-021-93847-9] [Reference Citation Analysis]
52 Yang Y, Kozel Z, Sharma P, Yaskiv O, Torres J, Pandya S, Jhaveri KD, Bhaskaran M, Vira M, Bijol V. Identifying patients with CKD risk at the time of nephrectomy: When to initiate nephrology consult. Journal of Onco-Nephrology 2021;5:105-13. [DOI: 10.1177/23993693211031918] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
53 Zacharias HU, Altenbuchinger M, Schultheiss UT, Raffler J, Kotsis F, Ghasemi S, Ali I, Kollerits B, Metzger M, Steinbrenner I, Sekula P, Massy ZA, Combe C, Kalra PA, Kronenberg F, Stengel B, Eckardt KU, Köttgen A, Schmid M, Gronwald W, Oefner PJ; GCKD investigators. A Predictive Model for Progression of CKD to Kidney Failure Based on Routine Laboratory Tests. Am J Kidney Dis 2021:S0272-6386(21)00729-0. [PMID: 34298143 DOI: 10.1053/j.ajkd.2021.05.018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
54 Deng Y, Li N, Wu Y, Wang M, Yang S, Zheng Y, Deng X, Xiang D, Zhu Y, Xu P, Zhai Z, Zhang D, Dai Z, Gao J. Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019. Front Endocrinol (Lausanne) 2021;12:672350. [PMID: 34276558 DOI: 10.3389/fendo.2021.672350] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
55 Periquito JS, Gladytz T, Millward JM, Delgado PR, Cantow K, Grosenick D, Hummel L, Anger A, Zhao K, Seeliger E, Pohlmann A, Waiczies S, Niendorf T. Continuous diffusion spectrum computation for diffusion-weighted magnetic resonance imaging of the kidney tubule system. Quant Imaging Med Surg 2021;11:3098-119. [PMID: 34249638 DOI: 10.21037/qims-20-1360] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
56 Shi Y, Li W, Duan F, Pu S, Peng H, Ha M, Luo Y. Factors promoting shared decision-making in renal replacement therapy for patients with end-stage kidney disease: systematic review and qualitative meta-synthesis. Int Urol Nephrol 2021. [PMID: 34159522 DOI: 10.1007/s11255-021-02913-8] [Reference Citation Analysis]
57 Escobar C, Aranda U, Palacios B, Capel M, Sicras A, Sicras A, Hormigo A, Alcázar R, Manito N, Botana M. Epidemiology, clinical profile, management, and two-year risk complications among patients with chronic kidney disease in Spain. Nefrologia 2021:S0211-6995(21)00101-6. [PMID: 34148667 DOI: 10.1016/j.nefro.2021.03.006] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Negi P, Cheke RS, Patil VM. Recent advances in pharmacological diversification of Src family kinase inhibitors. Egypt J Med Hum Genet 2021;22. [DOI: 10.1186/s43042-021-00172-x] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
59 Liu P, Quinn RR, Lam NN, Al-Wahsh H, Sood MM, Tangri N, Tonelli M, Ravani P. Progression and Regression of Chronic Kidney Disease by Age Among Adults in a Population-Based Cohort in Alberta, Canada. JAMA Netw Open 2021;4:e2112828. [PMID: 34100938 DOI: 10.1001/jamanetworkopen.2021.12828] [Cited by in Crossref: 1] [Cited by in F6Publishing: 12] [Article Influence: 1.0] [Reference Citation Analysis]
60 Zhang T, Wang Y, Zhang X, Wang W, Zhao G. The Impact of Bariatric Surgery on Renal Function: a Retrospective Analysis of Short-Term Outcomes. Obes Surg 2021;31:3476-82. [PMID: 34061302 DOI: 10.1007/s11695-021-05366-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Filipska A, Bohdan B, Wieczorek PP, Hudz N. Chronic kidney disease and dialysis therapy: incidence and prevalence in the world. PHAR 2021;68:463-70. [DOI: 10.3897/pharmacia.68.e65501] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
62 Chen R, Sun G, Liu R, Sun A, Cao Y, Zhou X, Zhang S. Hypertriglyceridemic waist phenotype and risk of chronic kidney disease in community-dwelling adults aged 60 years and older in Tianjin, China: a 7-year cohort study. BMC Nephrol 2021;22:182. [PMID: 34011292 DOI: 10.1186/s12882-021-02339-5] [Reference Citation Analysis]
63 Gu YY, Dou JY, Huang XR, Liu XS, Lan HY. Transforming Growth Factor-β and Long Non-coding RNA in Renal Inflammation and Fibrosis. Front Physiol 2021;12:684236. [PMID: 34054586 DOI: 10.3389/fphys.2021.684236] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
64 Ma X, Tao M, Hu Y, Tang L, Lu J, Shi Y, Chen H, Chen S, Wang Y, Cui B, Du L, Liang W, Huang G, Zhou X, Qiu A, Zhuang S, Zang X, Liu N. Clinical outcomes, quality of life, and costs evaluation of peritoneal dialysis management models in Shanghai Songjiang District: a multi-center and prospective cohort study. Ren Fail 2021;43:754-65. [PMID: 33913395 DOI: 10.1080/0886022X.2021.1918164] [Reference Citation Analysis]
65 Franzin R, Stasi A, Ranieri E, Netti GS, Cantaluppi V, Gesualdo L, Stallone G, Castellano G. Targeting Premature Renal Aging: from Molecular Mechanisms of Cellular Senescence to Senolytic Trials. Front Pharmacol 2021;12:630419. [PMID: 33995028 DOI: 10.3389/fphar.2021.630419] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
66 Zhang ZM, Yang L, Wan Y, Jiang S, Shang EX, Qian DW, Duan JA. The synergic renoprotective effect of Rehmanniae Radix Preparata and Corni Fructus on adenine-induced chronic kidney disease rats based on integrated plasma metabolomics and network pharmacology approach. Life Sci 2021;278:119545. [PMID: 33930370 DOI: 10.1016/j.lfs.2021.119545] [Reference Citation Analysis]
67 Nagai K, Asahi K, Iseki K, Yamagata K. Estimating the prevalence of definitive chronic kidney disease in the Japanese general population. Clin Exp Nephrol 2021;25:885-92. [PMID: 33839966 DOI: 10.1007/s10157-021-02049-0] [Reference Citation Analysis]
68 Li N, Huang H, Linsheng L, Lu H, Liu X. Improving glomerular filtration rate estimation by semi-supervised learning: a development and external validation study. Int Urol Nephrol 2021;53:1649-58. [PMID: 33710531 DOI: 10.1007/s11255-020-02771-w] [Reference Citation Analysis]
69 Ehrich J, Dubourg L, Hansson S, Pape L, Steinle T, Fruth J, Höckner S, Schiffer E. Serum Myo-Inositol, Dimethyl Sulfone, and Valine in Combination with Creatinine Allow Accurate Assessment of Renal Insufficiency-A Proof of Concept. Diagnostics (Basel) 2021;11:234. [PMID: 33546466 DOI: 10.3390/diagnostics11020234] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
70 Kim H, Yu MR, Lee H, Kwon SH, Jeon JS, Han DC, Noh H. Metformin inhibits chronic kidney disease-induced DNA damage and senescence of mesenchymal stem cells. Aging Cell 2021;20:e13317. [PMID: 33524231 DOI: 10.1111/acel.13317] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 11.0] [Reference Citation Analysis]
71 Schiffer L, Gertges R, Nöhre M, Schieffer E, Tegtbur U, Pape L, de Zwaan M, Schiffer M. Use and preferences regarding internet-based health care delivery in patients with chronic kidney disease. BMC Med Inform Decis Mak 2021;21:34. [PMID: 33522934 DOI: 10.1186/s12911-020-01375-9] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
72 Lu Z, Ji C, Luo X, Lan Y, Han L, Chen Y, Liu X, Lin Q, Lu F, Wu X, Guo R, Zou C. Nanoparticle-Mediated Delivery of Emodin via Colonic Irrigation Attenuates Renal Injury in 5/6 Nephrectomized Rats. Front Pharmacol 2020;11:606227. [PMID: 33551808 DOI: 10.3389/fphar.2020.606227] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
73 Li Q, Fan QL, Han QX, Geng WJ, Zhao HH, Ding XN, Yan JY, Zhu HY. Machine learning in nephrology: scratching the surface. Chin Med J (Engl) 2020;:687-98. [PMID: 32049747 DOI: 10.1097/CM9.0000000000000694] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
74 Chan KW, Kwong ASK, Tsui PN, Cheung SCY, Chan GCW, Choi WF, Yiu WH, Zhang Y, Wong MM, Zhang ZJ, Tan KCB, Lao L, Tang SCW. Efficacy, safety and response predictors of adjuvant astragalus for diabetic kidney disease (READY): study protocol of an add-on, assessor-blind, parallel, pragmatic randomised controlled trial. BMJ Open 2021;11:e042686. [PMID: 33436470 DOI: 10.1136/bmjopen-2020-042686] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
75 Mei Q, Wang AY, Bryant A, Yang Y, Li M, Wang F, Du S, Kurts C, Wu P, Ma K, Wu L, Chen H, Luo J, Li Y, Hu G, Yuan X, Li J. Survival Factors and Metabolic Pathogenesis in Elderly Patients (≥65) With COVID-19: A Multi-Center Study. Front Med (Lausanne) 2020;7:595503. [PMID: 33585504 DOI: 10.3389/fmed.2020.595503] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
76 Yu Z, Xiong J, Yang K, Huang Y, He T, Yu Y, Zhao J. The association between platelet indices and cardiovascular events in chronic kidney disease patients without dialysis. Int Urol Nephrol 2021;53:961-71. [PMID: 33387224 DOI: 10.1007/s11255-020-02696-4] [Reference Citation Analysis]
77 Li J, Yang Y, Wei S, Chen L, Xue L, Tian H, Tao S. Bixin Protects Against Kidney Interstitial Fibrosis Through Promoting STAT6 Degradation. Front Cell Dev Biol 2020;8:576988. [PMID: 33313043 DOI: 10.3389/fcell.2020.576988] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Fujitaka K, Murakami T, Takeuchi M, Kakimoto T, Mochida H, Arakawa K. mRNAs in urinary nano-extracellular vesicles as potential biomarkers for non-invasive kidney biopsy. Biomed Rep 2021;14:11. [PMID: 33235726 DOI: 10.3892/br.2020.1387] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
79 Safarpour Y, Vaziri ND, Jabbari B. Movement Disorders in Chronic Kidney Disease - A Descriptive Review. J Stroke Cerebrovasc Dis 2021;30:105408. [PMID: 33139171 DOI: 10.1016/j.jstrokecerebrovasdis.2020.105408] [Reference Citation Analysis]
80 Zhou S, Wu Q, Lin X, Ling X, Miao J, Liu X, Hu C, Zhang Y, Jia N, Hou FF, Liu Y, Zhou L. Cannabinoid receptor type 2 promotes kidney fibrosis through orchestrating β-catenin signaling. Kidney Int 2021;99:364-81. [PMID: 33152447 DOI: 10.1016/j.kint.2020.09.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
81 Satarug S, C Gobe G, A Vesey D, Phelps KR. Cadmium and Lead Exposure, Nephrotoxicity, and Mortality. Toxics 2020;8:E86. [PMID: 33066165 DOI: 10.3390/toxics8040086] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
82 You R, Zhou W, Li Y, Zhang Y, Huang S, Jia Z, Zhang A. Inhibition of ROCK2 alleviates renal fibrosis and the metabolic disorders in the proximal tubular epithelial cells. Clin Sci (Lond) 2020;134:1357-76. [PMID: 32490513 DOI: 10.1042/CS20200030] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
83 Gomes MB, Pizarro MH, Muniz LH, Barros BSV, Melo LGN, Santos DC, Negrato CA. Prevalence of chronic kidney disease in an admixed population of patients with type 1 diabetes. A multicenter study in Brazil. Diabetes Res Clin Pract 2020;170:108490. [PMID: 33010359 DOI: 10.1016/j.diabres.2020.108490] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
84 Aseneh JB, Kemah BA, Mabouna S, Njang ME, Ekane DSM, Agbor VN. Chronic kidney disease in Cameroon: a scoping review. BMC Nephrol 2020;21:409. [PMID: 32967645 DOI: 10.1186/s12882-020-02072-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
85 Machluf Y, Chaiter Y, Tal O. Gender medicine: Lessons from COVID-19 and other medical conditions for designing health policy. World J Clin Cases 2020; 8(17): 3645-3668 [PMID: 32953842 DOI: 10.12998/wjcc.v8.i17.3645] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
86 Walbaum M, Scholes S, Pizzo E, Paccot M, Mindell JS. Chronic kidney disease in adults aged 18 years and older in Chile: findings from the cross-sectional Chilean National Health Surveys 2009-2010 and 2016-2017. BMJ Open 2020;10:e037720. [PMID: 32883732 DOI: 10.1136/bmjopen-2020-037720] [Reference Citation Analysis]
87 Chen YH, Chen HL, Fan HC, Tung YT, Kuo CW, Tu MY, Chen CM. Anti-Inflammatory, Antioxidant, and Antifibrotic Effects of Kefir Peptides on Salt-Induced Renal Vascular Damage and Dysfunction in Aged Stroke-Prone Spontaneously Hypertensive Rats. Antioxidants (Basel) 2020;9:E790. [PMID: 32858955 DOI: 10.3390/antiox9090790] [Cited by in Crossref: 5] [Cited by in F6Publishing: 12] [Article Influence: 2.5] [Reference Citation Analysis]
88 de Carvalho Ribeiro P, Oliveira LF, Filho MA, Caldas HC. Differentiating Induced Pluripotent Stem Cells into Renal Cells: A New Approach to Treat Kidney Diseases. Stem Cells Int 2020;2020:8894590. [PMID: 32831854 DOI: 10.1155/2020/8894590] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
89 Chen H, Fan Y, Jing H, Tang S, Zhou J. Emerging role of lncRNAs in renal fibrosis. Arch Biochem Biophys 2020;692:108530. [PMID: 32768395 DOI: 10.1016/j.abb.2020.108530] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
90 Li J, Yang Y, Wei S, Chen L, Xue L, Tian H, Tao S. Bixin Confers Prevention against Ureteral Obstruction-Caused Renal Interstitial Fibrosis through Activation of the Nuclear Factor Erythroid-2-Related Factor2 Pathway in Mice. J Agric Food Chem 2020;68:8321-9. [PMID: 32706966 DOI: 10.1021/acs.jafc.0c03674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Lee H, Fessler MB, Qu P, Heymann J, Kopp JB. Macrophage polarization in innate immune responses contributing to pathogenesis of chronic kidney disease. BMC Nephrol 2020;21:270. [PMID: 32660446 DOI: 10.1186/s12882-020-01921-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 24] [Article Influence: 6.5] [Reference Citation Analysis]
92 Díaz-medina BA, Guerreiro-vieira-da-silva D. Las experiencias de incertidumbre de jóvenes mexicanos en tratamiento de diálisis peritoneal. Enferm Nefrol. [DOI: 10.37551/s2254-28842020015] [Reference Citation Analysis]
93 Cai T, Karlaftis V, Hearps S, Matthews S, Burgess J, Monagle P, Ignjatovic V; on behalf of the HAPPI Kids study team. Reference intervals for serum cystatin C in neonates and children 30 days to 18 years old. Pediatr Nephrol 2020;35:1959-66. [DOI: 10.1007/s00467-020-04612-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
94 Zhao Y, Li Y, Li J, Song W, Zhao J, Xu Y, Zhai Y, Xu S. Reporting quality of chronic kidney disease practice guidelines according to the RIGHT statement: a systematic analysis. Ther Adv Chronic Dis 2020;11:2040622320922017. [PMID: 32523665 DOI: 10.1177/2040622320922017] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
95 Hu JN, Xu XY, Jiang S, Liu Y, Liu Z, Wang YP, Gong XJ, Li KK, Ren S, Li W. Protective effect of ginsenoside Rk1, a major rare saponin from black ginseng, on cisplatin-induced nephrotoxicity in HEK-293 cells. Kaohsiung J Med Sci 2020;36:732-40. [PMID: 32374939 DOI: 10.1002/kjm2.12220] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
96 Chung CS, Lee JH, Jang SH, Cho NJ, Kim WJ, Heo NH, Gil HW, Lee EY, Moon JS, Park S. Age-adjusted global glomerulosclerosis predicts renal progression more accurately in patients with IgA nephropathy. Sci Rep 2020;10:6270. [PMID: 32286437 DOI: 10.1038/s41598-020-63366-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
97 Thongprayoon C, Kaewput W, Kovvuru K, Hansrivijit P, Kanduri SR, Bathini T, Chewcharat A, Leeaphorn N, Gonzalez-Suarez ML, Cheungpasitporn W. Promises of Big Data and Artificial Intelligence in Nephrology and Transplantation. J Clin Med 2020;9:E1107. [PMID: 32294906 DOI: 10.3390/jcm9041107] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
98 Nunes S, Alves A, Preguiça I, Barbosa A, Vieira P, Mendes F, Martins D, Viana SD, Reis F. Crescent-Like Lesions as an Early Signature of Nephropathy in a Rat Model of Prediabetes Induced by a Hypercaloric Diet. Nutrients 2020;12:E881. [PMID: 32218109 DOI: 10.3390/nu12040881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
99 Agudelo-Botero M, Valdez-Ortiz R, Giraldo-Rodríguez L, González-Robledo MC, Mino-León D, Rosales-Herrera MF, Cahuana-Hurtado L, Rojas-Russell ME, Dávila-Cervantes CA. Overview of the burden of chronic kidney disease in Mexico: secondary data analysis based on the Global Burden of Disease Study 2017. BMJ Open 2020;10:e035285. [PMID: 32213523 DOI: 10.1136/bmjopen-2019-035285] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 8.5] [Reference Citation Analysis]
100 Donovan J, Al Hamarneh YN, Bajorek B, Papastergiou J, Tsuyuki RT. Community pharmacist identification of chronic kidney disease using point-of-care technology: A pilot study. Can Pharm J (Ott) 2020;153:84-7. [PMID: 32206152 DOI: 10.1177/1715163520902495] [Reference Citation Analysis]
101 Mantovani A, Taliento A, Zusi C, Baselli G, Prati D, Granata S, Zaza G, Colecchia A, Maffeis C, Byrne CD, Valenti L, Targher G. PNPLA3 I148M gene variant and chronic kidney disease in type 2 diabetic patients with NAFLD: Clinical and experimental findings. Liver Int 2020;40:1130-41. [PMID: 32125756 DOI: 10.1111/liv.14419] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
102 Liu J, Li Y, Dai J, Lin B, Xiao C, Zhang X, Luo L, Wang T, Li X, Yu Y, Chen S, Wu L, Liu Y, Yu X, Qin X. Comprehensive Analyses of the Immunoglobulin Proteome for the Classification of Glomerular Diseases. J Proteome Res 2020;19:1502-12. [DOI: 10.1021/acs.jproteome.9b00748] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
103 Satarug S, Gobe GC, Ujjin P, Vesey DA. A Comparison of the Nephrotoxicity of Low Doses of Cadmium and Lead. Toxics 2020;8:E18. [PMID: 32131418 DOI: 10.3390/toxics8010018] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
104 GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet 2020;395:709-33. [PMID: 32061315 DOI: 10.1016/S0140-6736(20)30045-3] [Cited by in Crossref: 1393] [Cited by in F6Publishing: 1066] [Article Influence: 696.5] [Reference Citation Analysis]
105 Gu YY, Liu XS, Huang XR, Yu XQ, Lan HY. Diverse Role of TGF-β in Kidney Disease. Front Cell Dev Biol 2020;8:123. [PMID: 32258028 DOI: 10.3389/fcell.2020.00123] [Cited by in Crossref: 30] [Cited by in F6Publishing: 70] [Article Influence: 15.0] [Reference Citation Analysis]
106 Costa-moreira P, Vilas-boas F, Teixeira Fraga A, Macedo G. Particular aspects of gastroenterological disorders in chronic kidney disease and end-stage renal disease patients: a clinically focused review. Scandinavian Journal of Gastroenterology 2020;55:129-38. [DOI: 10.1080/00365521.2020.1722217] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
107 Xiao H, Xiong C, Shao X, Gao P, Chen H, Ning J, Chen Y, Zou Z, Hong G, Li X, You X, Sheng J, Wu F, Wang X, Zou H. Visceral Adiposity Index and Chronic Kidney Disease in a Non-Diabetic Population: A Cross-Sectional Study. Diabetes Metab Syndr Obes 2020;13:257-65. [PMID: 32099432 DOI: 10.2147/DMSO.S231656] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
108 Paterson EN, Ravindran ML, Griffiths K, Le Velly CA, Cardwell CC, McCarter RV, Nicol P, Chhablani JK, Rasheed MA, Vupparaboina KK, MacGillivray TJ, Harbinson M, Maxwell AP, Hogg RE, McKay GJ. Association of reduced inner retinal thicknesses with chronic kidney disease. BMC Nephrol 2020;21:37. [PMID: 32005180 DOI: 10.1186/s12882-019-1679-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
109 Brar A, Markell M. Impact of gender and gender disparities in patients with kidney disease. Curr Opin Nephrol Hypertens. 2019;28:178-182. [PMID: 30652978 DOI: 10.1097/mnh.0000000000000482] [Cited by in Crossref: 14] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
110 Preguiça I, Alves A, Nunes S, Gomes P, Fernandes R, Viana SD, Reis F. Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy.Nutrients. 2020;12. [PMID: 31963709 DOI: 10.3390/nu12010250] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
111 Krishnan A, Chandra Y, Malani J, Jesudason S, Sen S, Ritchie AG. End-stage kidney disease in Fiji. Intern Med J 2019;49:461-6. [PMID: 30230153 DOI: 10.1111/imj.14108] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
112 Liu P, Quinn RR, Karim ME, Bello A, Tam-Tham H, Weaver R, Ronksley PE, Quan H, Strippoli GFM, Manns B, Hemmelgarn BR, Tonelli M, Ravani P. Nephrology consultation and mortality in people with stage 4 chronic kidney disease: a population-based study. CMAJ 2019;191:E274-82. [PMID: 30858183 DOI: 10.1503/cmaj.181372] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
113 de Haan A, Eijgelsheim M, Vogt L, Knoers NVAM, de Borst MH. Diagnostic Yield of Next-Generation Sequencing in Patients With Chronic Kidney Disease of Unknown Etiology. Front Genet 2019;10:1264. [PMID: 31921302 DOI: 10.3389/fgene.2019.01264] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
114 Li S, Lin Q, Shao X, Zhu X, Wu J, Wu B, Zhang M, Zhou W, Zhou Y, Jin H, Zhang Z, Qi C, Shen J, Mou S, Gu L, Ni Z. Drp1-regulated PARK2-dependent mitophagy protects against renal fibrosis in unilateral ureteral obstruction. Free Radic Biol Med 2020;152:632-49. [PMID: 31825802 DOI: 10.1016/j.freeradbiomed.2019.12.005] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
115 Fabrizi F, Cerutti R, Dixit V, Messa P. The impact of antiviral therapy for HCV on kidney disease: a systematic review and meta-analysis. Nefrologia (Engl Ed) 2020;40:299-310. [PMID: 31813592 DOI: 10.1016/j.nefro.2019.07.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
116 Izeidi PPM, Nlandu YM, Lepira FB, Makulo JR, Engole YM, Mokoli VM, Bukabau JB, Kwilu FN, Nseka NM, Sumaili EK. Cost estimate of chronic hemodialysis in Kinshasa, the Democratic Republic of the Congo: A prospective study in two centers. Hemodialysis International 2019;24:121-8. [DOI: 10.1111/hdi.12802] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
117 Park JS, Choi HI, Kim DH, Kim CS, Bae EH, Ma SK, Kim SW. RON Receptor Tyrosine Kinase Regulates Epithelial Mesenchymal Transition and the Expression of Pro-Fibrotic Markers via Src/Smad Signaling in HK-2 and NRK49F Cells. Int J Mol Sci 2019;20:E5489. [PMID: 31690042 DOI: 10.3390/ijms20215489] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
118 Mackay D, Mollard RC, Granger M, Bruce S, Blewett H, Carlberg J, Duhamel T, Eck P, Faucher P, Hamm NC, Khafipour E, Lix L, McMillan D, Myrie S, Ravandi A, Tangri N, Azad M, Jones PJ. The Manitoba Personalized Lifestyle Research (TMPLR) study protocol: a multicentre bidirectional observational cohort study with administrative health record linkage investigating the interactions between lifestyle and health in Manitoba, Canada. BMJ Open 2019;9:e023318. [PMID: 31604781 DOI: 10.1136/bmjopen-2018-023318] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
119 Francipane MG, Han B, Lagasse E. Host Lymphotoxin-β Receptor Signaling Is Crucial for Angiogenesis of Metanephric Tissue Transplanted into Lymphoid Sites. Am J Pathol 2020;190:252-69. [PMID: 31585070 DOI: 10.1016/j.ajpath.2019.08.018] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
120 Mantovani A, Zusi C, Sani E, Colecchia A, Lippi G, Zaza G, Valenti L, Byrne C, Maffeis C, Bonora E, Targher G. Association between PNPLA3rs738409 polymorphism decreased kidney function in postmenopausal type 2 diabetic women with or without non-alcoholic fatty liver disease. Diabetes & Metabolism 2019;45:480-7. [DOI: 10.1016/j.diabet.2019.01.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
121 Wu H, Lai CF, Chang-Panesso M, Humphreys BD. Proximal Tubule Translational Profiling during Kidney Fibrosis Reveals Proinflammatory and Long Noncoding RNA Expression Patterns with Sexual Dimorphism. J Am Soc Nephrol 2020;31:23-38. [PMID: 31537650 DOI: 10.1681/ASN.2019040337] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 6.7] [Reference Citation Analysis]
122 Kanbay M, Yerlikaya A, Sag AA, Ortiz A, Kuwabara M, Covic A, Wiecek A, Stenvinkel P, Afsar B. A journey from microenvironment to macroenvironment: the role of metaflammation and epigenetic changes in cardiorenal disease. Clin Kidney J 2019;12:861-70. [PMID: 31807301 DOI: 10.1093/ckj/sfz106] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
123 Wang L, Lin W, Chen J. Krüppel-like Factor 15: A Potential Therapeutic Target For Kidney Disease. Int J Biol Sci 2019;15:1955-61. [PMID: 31523196 DOI: 10.7150/ijbs.34838] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
124 Wei H, Yan Y, Gong J, Dong J. Prevalence of kidney damage in Chinese elderly: a large-scale population-based study. BMC Nephrol 2019;20:341. [PMID: 31477037 DOI: 10.1186/s12882-019-1525-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
125 Tsai YC, Wu CF, Liu CC, Hsieh TJ, Lin YT, Chiu YW, Hwang SJ, Chen HC, Wu MT. Urinary Melamine Levels and Progression of CKD. Clin J Am Soc Nephrol 2019;14:1133-41. [PMID: 31337620 DOI: 10.2215/CJN.01740219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
126 Moreno Velásquez I, Tribaldos Causadias M, Valdés R, Gómez B, Motta J, Cuero C, Herrera-Ballesteros V. End-stage renal disease-financial costs and years of life lost in Panama: a cost-analysis study. BMJ Open 2019;9:e027229. [PMID: 31133590 DOI: 10.1136/bmjopen-2018-027229] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
127 Kalyesubula R, Hau JP, Asiki G, Ssebunya B, Kusemererwa S, Seeley J, Smeeth L, Tomlinson L, Newton R. Impaired renal function in a rural Ugandan population cohort. Wellcome Open Res 2018;3:149. [PMID: 31223661 DOI: 10.12688/wellcomeopenres.14863.3] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
128 Kalyesubula R, Hau JP, Asiki G, Ssebunya B, Kusemererwa S, Seeley J, Smeeth L, Tomlinson L, Newton R. Impaired renal function in a rural Ugandan population cohort. Wellcome Open Res 2018;3:149. [PMID: 31223661 DOI: 10.12688/wellcomeopenres.14863.3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
129 Bowe B, Xie Y, Li T, Yan Y, Xian H, Al-Aly Z. Estimates of the 2016 global burden of kidney disease attributable to ambient fine particulate matter air pollution. BMJ Open 2019;9:e022450. [PMID: 31072847 DOI: 10.1136/bmjopen-2018-022450] [Cited by in Crossref: 28] [Cited by in F6Publishing: 37] [Article Influence: 9.3] [Reference Citation Analysis]
130 Smyth LJ, Cañadas-Garre M, Cappa RC, Maxwell AP, McKnight AJ. Genetic associations between genes in the renin-angiotensin-aldosterone system and renal disease: a systematic review and meta-analysis. BMJ Open 2019;9:e026777. [PMID: 31048445 DOI: 10.1136/bmjopen-2018-026777] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 7.7] [Reference Citation Analysis]
131 Bukabau JB, Yayo E, Gnionsahé A, Monnet D, Pottel H, Cavalier E, Nkodila A, Makulo JRR, Mokoli VM, Lepira FB, Nseka NM, Krzesinski J, Sumaili EK, Delanaye P. Performance of creatinine- or cystatin C–based equations to estimate glomerular filtration rate in sub-Saharan African populations. Kidney International 2019;95:1181-9. [DOI: 10.1016/j.kint.2018.11.045] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 10.7] [Reference Citation Analysis]
132 Pergola PE, Pecoits-Filho R, Winkelmayer WC, Spinowitz B, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB. Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review. Pharmacoecon Open 2019;3:463-78. [PMID: 30968369 DOI: 10.1007/s41669-019-0132-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
133 Teissier T, Quersin V, Gnemmi V, Daroux M, Howsam M, Delguste F, Lemoine C, Fradin C, Schmidt AM, Cauffiez C, Brousseau T, Glowacki F, Tessier FJ, Boulanger E, Frimat M. Knockout of receptor for advanced glycation end-products attenuates age-related renal lesions. Aging Cell 2019;18:e12850. [PMID: 30794349 DOI: 10.1111/acel.12850] [Cited by in Crossref: 24] [Cited by in F6Publishing: 22] [Article Influence: 8.0] [Reference Citation Analysis]
134 Chen L, Chen DQ, Liu JR, Zhang J, Vaziri ND, Zhuang S, Chen H, Feng YL, Guo Y, Zhao YY. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis. Exp Mol Med 2019;51:1-18. [PMID: 30918245 DOI: 10.1038/s12276-019-0234-2] [Cited by in Crossref: 39] [Cited by in F6Publishing: 55] [Article Influence: 13.0] [Reference Citation Analysis]
135 Gagnebin Y, Pezzatti J, Lescuyer P, Boccard J, Ponte B, Rudaz S. Toward a better understanding of chronic kidney disease with complementary chromatographic methods hyphenated with mass spectrometry for improved polar metabolome coverage. J Chromatogr B Analyt Technol Biomed Life Sci 2019;1116:9-18. [PMID: 30951967 DOI: 10.1016/j.jchromb.2019.03.031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
136 Satarug S, Vesey DA, Nishijo M, Ruangyuttikarn W, Gobe GC. The inverse association of glomerular function and urinary β2-MG excretion and its implications for cadmium health risk assessment. Environ Res 2019;173:40-7. [PMID: 30889420 DOI: 10.1016/j.envres.2019.03.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
137 Bevc S, Hojs N, Knehtl M, Ekart R, Hojs R. Cystatin C as a predictor of mortality in elderly patients with chronic kidney disease. Aging Male 2019;22:62-7. [PMID: 29912597 DOI: 10.1080/13685538.2018.1479386] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
138 Díaz-medina BA, Mercado-martínez FJ. Obstáculos y estrategias de afrontamiento en la atención renal: estudio cualitativo en jóvenes con enfermedad renal crónica en diálisis peritoneal. Saude soc 2019;28:275-86. [DOI: 10.1590/s0104-12902019180724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
139 Tziastoudi M, Stefanidis I, Stravodimos K, Zintzaras E; The Family Investigation of Nephropathy and Diabetes (FIND) Consortium. Identification of Chromosomal Regions Linked to Diabetic Nephropathy: A Meta-Analysis of Genome-Wide Linkage Scans. Genetic Testing and Molecular Biomarkers 2019;23:105-17. [DOI: 10.1089/gtmb.2018.0209] [Cited by in Crossref: 4] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
140 Ravizza S, Huschto T, Adamov A, Böhm L, Büsser A, Flöther FF, Hinzmann R, König H, McAhren SM, Robertson DH, Schleyer T, Schneidinger B, Petrich W. Predicting the early risk of chronic kidney disease in patients with diabetes using real-world data. Nat Med 2019;25:57-9. [PMID: 30617317 DOI: 10.1038/s41591-018-0239-8] [Cited by in Crossref: 53] [Cited by in F6Publishing: 62] [Article Influence: 17.7] [Reference Citation Analysis]
141 Kanlaya R, Thongboonkerd V. Protective Effects of Epigallocatechin-3-Gallate from Green Tea in Various Kidney Diseases. Adv Nutr 2019;10:112-21. [PMID: 30615092 DOI: 10.1093/advances/nmy077] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 8.0] [Reference Citation Analysis]
142 Nguyen NTQ, Cockwell P, Maxwell AP, Griffin M, O'Brien T, O'Neill C. Chronic kidney disease, health-related quality of life and their associated economic burden among a nationally representative sample of community dwelling adults in England. PLoS One 2018;13:e0207960. [PMID: 30475893 DOI: 10.1371/journal.pone.0207960] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
143 Chartier MJ, Tangri N, Komenda P, Walld R, Koseva I, Burchill C, McGowan KL, Dart A. Prevalence, socio-demographic characteristics, and comorbid health conditions in pre-dialysis chronic kidney disease: results from the Manitoba chronic kidney disease cohort. BMC Nephrol 2018;19:255. [PMID: 30305038 DOI: 10.1186/s12882-018-1058-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
144 Fernandes R, Viana SD, Nunes S, Reis F. Diabetic gut microbiota dysbiosis as an inflammaging and immunosenescence condition that fosters progression of retinopathy and nephropathy. Biochim Biophys Acta Mol Basis Dis. 2019;1865:1876-1897. [PMID: 30287404 DOI: 10.1016/j.bbadis.2018.09.032] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 10.0] [Reference Citation Analysis]
145 Roediger B, Lee Q, Tikoo S, Cobbin JCA, Henderson JM, Jormakka M, O'Rourke MB, Padula MP, Pinello N, Henry M, Wynne M, Santagostino SF, Brayton CF, Rasmussen L, Lisowski L, Tay SS, Harris DC, Bertram JF, Dowling JP, Bertolino P, Lai JH, Wu W, Bachovchin WW, Wong JJ, Gorrell MD, Shaban B, Holmes EC, Jolly CJ, Monette S, Weninger W. An Atypical Parvovirus Drives Chronic Tubulointerstitial Nephropathy and Kidney Fibrosis. Cell 2018;175:530-543.e24. [PMID: 30220458 DOI: 10.1016/j.cell.2018.08.013] [Cited by in Crossref: 45] [Cited by in F6Publishing: 34] [Article Influence: 11.3] [Reference Citation Analysis]
146 Fan Y, Jin X, Man C, Gong D. Association of serum gamma-glutamyltransferase with chronic kidney disease risk: a meta-analysis. Free Radical Research 2018;52:819-25. [DOI: 10.1080/10715762.2018.1492120] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
147 Mantovani A, Rigolon R, Turino T, Pichiri I, Falceri A, Rossi A, Temporelli PL, Bonapace S, Lippi G, Zoppini G, Bonora E, Byrne CD, Targher G. Association between decreasing estimated glomerular filtration rate and risk of cardiac conduction defects in patients with type 2 diabetes. Diabetes Metab 2018;44:473-81. [PMID: 30195089 DOI: 10.1016/j.diabet.2018.08.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
148 Xie Y, Bowe B, Mokdad AH, Xian H, Yan Y, Li T, Maddukuri G, Tsai C, Floyd T, Al-aly Z. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney International 2018;94:567-81. [DOI: 10.1016/j.kint.2018.04.011] [Cited by in Crossref: 212] [Cited by in F6Publishing: 172] [Article Influence: 53.0] [Reference Citation Analysis]
149 Charytoniuk T, Małyszko M, Bączek J, Fiedorczuk P, Siedlaczek K, Małyszko J. Progression to chronic kidney disease in patients undergoing nephrectomy for small renal masses: a price to pay for a therapeutic success? Postgrad Med 2018;130:613-20. [PMID: 30106608 DOI: 10.1080/00325481.2018.1511211] [Reference Citation Analysis]
150 Hirst JA, Montes MDV, Taylor CJ, Ordóñez-Mena JM, Ogburn E, Sharma V, Shine B, James T, Hobbs FR. Impact of a single eGFR and eGFR-estimating equation on chronic kidney disease reclassification: a cohort study in primary care. Br J Gen Pract 2018;68:e524-30. [PMID: 29970394 DOI: 10.3399/bjgp18X697937] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
151 Silva RE, Baldim JL, Chagas-Paula DA, Soares MG, Lago JHG, Gonçalves RV, Novaes RD. Predictive metabolomic signatures of end-stage renal disease: A multivariate analysis of population-based data. Biochimie 2018;152:14-30. [PMID: 29913183 DOI: 10.1016/j.biochi.2018.06.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
152 Wang Q, Liang Y, Qiao Y, Zhao X, Yang Y, Yang S, Li B, Zhao Q, Dong L, Quan S, Tian R, Liu Z. Expression of soluble epoxide hydrolase in renal tubular epithelial cells regulates macrophage infiltration and polarization in IgA nephropathy. Am J Physiol Renal Physiol 2018;315:F915-26. [PMID: 29717935 DOI: 10.1152/ajprenal.00534.2017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
153 Satarug S. Dietary Cadmium Intake and Its Effects on Kidneys. Toxics 2018;6:E15. [PMID: 29534455 DOI: 10.3390/toxics6010015] [Cited by in Crossref: 87] [Cited by in F6Publishing: 71] [Article Influence: 21.8] [Reference Citation Analysis]
154 Koye DN, Magliano DJ, Nelson RG, Pavkov ME. The Global Epidemiology of Diabetes and Kidney Disease. Adv Chronic Kidney Dis 2018;25:121-32. [PMID: 29580576 DOI: 10.1053/j.ackd.2017.10.011] [Cited by in Crossref: 160] [Cited by in F6Publishing: 134] [Article Influence: 40.0] [Reference Citation Analysis]
155 Mangion K, McDowell K, Mark PB, Rutherford E. Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic Review. Curr Cardiovasc Imaging Rep 2018;11:2. [PMID: 29497467 DOI: 10.1007/s12410-018-9441-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
156 Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol 2018;14:151-64. [PMID: 29355169 DOI: 10.1038/nrneph.2017.181] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
157 Carrero JJ, Hecking M, Chesnaye NC, Jager KJ. Sex and gender disparities in the epidemiology and outcomes of chronic kidney disease. Nat Rev Nephrol. 2018;14:151-164. [PMID: 29355169 DOI: 10.1038/nrneph.2017.181] [Cited by in Crossref: 142] [Cited by in F6Publishing: 210] [Article Influence: 35.5] [Reference Citation Analysis]
158 Wang N, Ning Z, Xia F, Chen C, Cheng J, Chen Y, Lu Y. Exposure to famine in early life and chronic kidney diseases in adulthood. Nutr Diabetes 2018;8:4. [PMID: 29335447 DOI: 10.1038/s41387-017-0014-9] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
159 Cocchiaro P, De Pasquale V, Della Morte R, Tafuri S, Avallone L, Pizard A, Moles A, Pavone LM. The Multifaceted Role of the Lysosomal Protease Cathepsins in Kidney Disease. Front Cell Dev Biol 2017;5:114. [PMID: 29312937 DOI: 10.3389/fcell.2017.00114] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
160 Zhang J, Zhang X, Zhao Y, Lv G. Association Between Urinary Alpha1-Microglobulin Levels and Nonalcoholic Fatty Liver Disease: A Cross-Sectional Study. Ann Nutr Metab 2018;72:30-6. [PMID: 29232673 DOI: 10.1159/000484255] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
161 Chung J, Shaw AS. TRP'ing up chronic kidney disease. Science 2017;358:1256-7. [DOI: 10.1126/science.aar3572] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
162 Trocchi P, Girndt M, Scheidt-Nave C, Markau S, Stang A. Impact of the estimation equation for GFR on population-based prevalence estimates of kidney dysfunction. BMC Nephrol 2017;18:341. [PMID: 29183273 DOI: 10.1186/s12882-017-0749-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
163 Romagnani P, Remuzzi G, Glassock R, Levin A, Jager KJ, Tonelli M, Massy Z, Wanner C, Anders H. Chronic kidney disease. Nat Rev Dis Primers 2017;3. [DOI: 10.1038/nrdp.2017.88] [Cited by in Crossref: 192] [Cited by in F6Publishing: 253] [Article Influence: 38.4] [Reference Citation Analysis]
164 Mantovani A, Zaza G, Byrne CD, Lonardo A, Zoppini G, Bonora E, Targher G. Nonalcoholic fatty liver disease increases risk of incident chronic kidney disease: A systematic review and meta-analysis. Metabolism. 2018;79:64-76. [PMID: 29137912 DOI: 10.1016/j.metabol.2017.11.003] [Cited by in Crossref: 171] [Cited by in F6Publishing: 147] [Article Influence: 34.2] [Reference Citation Analysis]
165 Han S, Yang K, Sun J, Liu J, Zhang L, Zhao J. Proteomics Investigations into Serum Proteins Adsorbed by High-Flux and Low-Flux Dialysis Membranes. Proteomics Clin Appl 2017;11. [PMID: 28795537 DOI: 10.1002/prca.201700079] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
166 Herrera-Añazco P, Taype-Rondan A, Lazo-Porras M, Alberto Quintanilla E, Ortiz-Soriano VM, Hernandez AV. Prevalence of chronic kidney disease in Peruvian primary care setting. BMC Nephrol 2017;18:246. [PMID: 28724362 DOI: 10.1186/s12882-017-0655-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
167 Wang J, Zhuang S. Src family kinases in chronic kidney disease. Am J Physiol Renal Physiol 2017;313:F721-8. [PMID: 28615246 DOI: 10.1152/ajprenal.00141.2017] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 6.2] [Reference Citation Analysis]
168 Delanaye P, Glassock RJ, De Broe ME. Epidemiology of chronic kidney disease: think (at least) twice! Clin Kidney J 2017;10:370-4. [PMID: 28617483 DOI: 10.1093/ckj/sfw154] [Cited by in Crossref: 31] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]